Clinical Trial Update: Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease [NA]

View source ↗

Summary

A terminated clinical trial investigating NuCel (human amniotic tissue-derived allograft) for lumbar degenerative conditions reported results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Disc Disease
• Spinal Stenosis

Drugs mentioned

• NuCel (human amniotic tissue-derived allograft)

Snippet

Sponsor: OhioHealth | Conditions: Lumbar Degenerative Disc Disease, Spinal Stenosis | NA | Status: TERMINATED | Results posted: 2018-08-27